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Ab s t r Ac t
Objective: The goal of this paper was to develop a model of intestinal sepsis in the investigational animal. Materials and Methods: Sprague-
Dawley male rats of 4 weeks (n = 42) were used. Initially, a pilot study (n = 12) was performed and distributed in groups with 0.8 cc inoculum 
of Escherichia coli ATCC intraperitoneally administered at concentrations of 9, 7, and 6. Subsequently, concentrations of 9 CFU are used in 
two groups of rats with reductions of 11 cc. Finally, a randomized trial of 28 rats was initiated in three treatment groups after intraperitoneal 
infection. Biological models of blood and peritoneal fluid were observed, and histopathological study of intraperitoneal tissues was done. 
Results: Demise of 95% of the rats infected with E. coli UFC concentration was observed. The blood culture and peritoneal fluid culture was 
positive for the same strain in all of them. The formation of blisters on the liver surface and polymorphonuclear infiltration in organs was 
detected. Conclusion: The fatal dose of E. coli should be diluted for intraperitoneal injection.
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In t r o d u c t I o n
Throughout history, experimental animals have been used to 
create different models that help in igniting the causes, diagnosis, 
and treatment of diseases that affect humans and animals. 
They have also served as a contribution to biological teaching, 
development, production, and control of medicines and food.[1]
In the context of sepsis, there are a great number of animal 
models that try to replicate the physiopathology of human sepsis. 
However, we find insignificant differences between the two species 
and the development of septic process does not normally reproduce 
the conditions of human sepsis. First of all, sepsis in humans is a 
pathology of gradual and in animals is an insidious presentation. 
Sepsis is usually much more acute.[2] Second, experimental 
intervention happens in the early stages of sepsis, when the levels 
of inflammatory cytokines are elevated and organic and vascular 
damage is minimal, difference from the human being, where 
therapeutic intervention usually occurs when the cytokine response 
pro-inflammatory is changing to anti-inflammatory and the organic 
damage is already apparent. Third, it is common for the susceptible 
human population which is at the extremes of life (children and older 
adults), instead the animals that used for experimentation are young 
adults with no other comorbidities. Fourth, animals in most models 
do not receive full support treatment that includes mechanical 
ventilation, fluid therapy, non-toxic drugs tropics, antibiotherapy, 
enteral or parenteral nutritional support, and renal replacement 
therapy. Finally, the elapsed timed from the onset of symptoms to 
organ failure is much shorter in animal models, in which the process 
is completed in a few days. In humans, corresponding time for 
curing translates to weeks and organic failure is observed usually 
in weeks. All these severely affect the evaluation of drug therapists 
sepsis.[3] And hence, there is no suitable model, each model has 
advantages and disadvantages depending on the parameter to be 
studied and the experimental animation employee. One of the most 
widely used animal experimentations modelized is created from 
injection, both local and systemic live bacteria, often Escherichia 
coli or of bacterial products or endotoxins such as LPL.[4] The use of 
endotoxins presents a large amount of limitations in rodents, the 
main one being the high dose needed to produce a state of shock, 
which is between 12 and 90 times higher than in humans. On the 
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other hand, there are clinical differences that endotoxin induces in 
rodents and in humans.[5,6] Other models are generated from the 
manipulation of the intestine and discharge of fecal content into 
the peritoneal cavity generating a polymicrobial peritonitis and as 
a consequence a systemic inflammatory response occurs. The most 
widely used procedure to generate model of rodent peritonitis is 
ligation and puncture. This model is suitable for evaluating therapies 
that act on changing pathophysiological bios produced during the 
septic process. The frequently used approach has been considered 
the “gold standard” technique.[7,8] Given the few reproducible sepsis 
models in the literature, we aim to develop and standardize a model 
of abdominal sepsis in an experimental animal by inoculation of E. 
coli with a single puncture in the peritoneal cavity.
MAt e r I A l s A n d Me t h o d s
Experimental Animals and Conditions
An experimental study (trial therapeutic) of intra-abdominal 
infection where the Sprague Dawley rat is experimental animal, 
Harlan Laboratories Models SL, male, 4 weeks and 90–110 gm. 
After adaptation week and before experimentation, all animals 
reach weights between 245 and 275 g. Experiment is carried out 
at the same time, to avoid possible inflow of the circadian cycle in 
the results of the work. All the animals were healthy and did not 
receive prior treatment. Animals are kept on food and water ad 
libitum, with a ½ day cycle of light and ½ day cycle of darkness, 
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and ambient temperature of 21 ± 3°C with relative humidity of 
the air of 55–74% and with 16–21 renovations/hour without recur 
air flow. They are housed in accordance with RD 52/2012 and in 
group to promote group behavioral skills. They also stay a week 
in these environmental conditions, to allow its adaptation, before 
the start of the study. A permanent marking is made on the tail 
of rats, to be able to do individual monitoring of the welfare 
state of each one of them. The localization of animals and their 
housing is carried out in the animal cited Translational Research 
Unit. All experimental procedures are performed in according 
to the guidelines of the European regulations for the protection 
of experimental animals. The study has been approved by the 
Ethical Committee for Animal. Conventional and biological waste 
is removed and disposed of regularly, safely, and in accordance 
with the institutional protocols.
Animal Working Model
Determination of lethal dose (pilot study)
Initially, a pilot study is carried out with n = 12, distributing them 
in groups with .9 ml inoculum of E. coli ATCC intraperitoneal in 
concentrations of 9, 7, and 6 CFU. In a second study (n = 8) with 
distribution in two groups, 1 ml of E. coli 11 UCF are used, being 
diluted in 12 and 16 ml of distilled water for vaccination. For the 
creation of the peritonitis model, an intraperitoneal section in 
rats with weights between 270 and 280 g, after anesthesia with 
ketamine.
The preparation of the inoculum is carried out in distilled 
water with a suspension of E. coli ATCC at different concentrations 
of colony-forming units per milliliter. Initially, the inoculum 
concentration is compared on a spectrophotometer and check 
with a spectrometer DADE. Starting from this suspension, many 
tubes are prepared for rats to undergo vaccination, adding to 0.9 
ml of the suspension to account for the milliliters of distilled water 
to be tested. It is checked that the bacterial concentration adjusts 
to what is expected using serial dilutions. After extension, control 
and reading are performed at 19–23 at 36°C.
The time elapsed between the preparation of the inoculation 
and immunization is always <2 h in all cases under the study.
Therapeutic study
Once the lethal dose has been found, randomization is performed 
in three groups of animals: Group I (with physiological serum), 
Group II (with ceftriaxone), and Group III (with ceftriaxone plus 
allicin). Inclusion of nine rats in group without (knowledge of the 
lethal dose and application of the principle of the three Rs.) and 12 
rats in Groups II and III. For the calculation of sample size, studies 
of contemporary models are taken into account.[4,7,8] and the 
standards on which the principles are based and ethics to minimize 
the use of animals in research: The three “Rs:” Reduce, Replace, and 
Refine. A model of peritonitis is generated in all groups. Rats from 
different groups are never housed in the same shelf. During the 
test, when the animal dies within the first 30 h, microbiological 
culture of liquid peritoneal and samples are taken from the 
liver, kidney, intestine, and peritoneum for histopathological 
evaluation. With the rest of the animals are expected on the 7th day 
of treatment. To observe the effects, MR scans on a low intensity 
0.35T system are taken to account for better soft-tissue contrast of 
MRI scans compared to CT scans.[9] The parameters evaluated are 
congestion liver, polymorphonuclear (PMN) in liver sinusoids, liver 
and peritoneal surface PMN, and colonization of bacteria on the 
surface of the liver and peritoneum.
re s u lts
Pilot Study
Twelve rats are used to conduct the study gave a pilot (four for 
each of the indicated concentrations). With these concentrations 
and dilution, it is observed that all rats survive after intraperitoneal 
injection despite the absence of antibiotic treatment. In this study, 
there is a possibility of increasing the dilution volume to 11 ml 
using the highest concentration of 9 CFU/ml. Of the analyzed 
cases, only one of them dies before 24 h. Finally, it is established 
that the optimal volume to produce 95% of deaths in the first 5 h 
of the animal is 17.
Therapeutic Trial
Subsequently, we determined the optimal concentration and 
dilution to cause peritonitis effective cases in the pilot study 
the therapeutic trial is performed with the dilution of 14 ml of 
distilled water in Group I (control), all rats die within 5–7 h. In all 
of them samples of peritoneal fluid and blood verified that E. coli 
strain is found with identical antibiotic sensitivity to that used for 
inoculation. In Groups II and III at the same time as inoculation 
occurs, are treated with an antibiotic. It is observed that all survive 
(24 rats) except one, in which E. coli strain is verified in the analysis 
of peritoneal fluid with similar sensitivity in antibiogram. When 
the animal dies within the first 24 h, peritoneal fluid culture 
is performed. In all observed cases, the growth of E. coli with 
identical anti-sensitivity biotic to that used in inoculation. In the 
histopathological evaluation, formation of swellings on the surface 
of the liver, large infiltration of PMN cells, and bacterial colonies 
happens. We can also see PMN and abundant colonies of E. coli on 
the peritoneal surface.
dI s c u s s I o n
Some authors stress the importance of achieving a standardized 
model in which the septic process is induced in an easy and 
reproducible way. Same authors created model of peritonitis 
from fecal material of origin human. Feces are collected and 
processed as per a protocol and are injected intraperitoneally into 
animals.[10] Another study of the models tested the placement 
of a stent in the ascending colon wall (colon ascenders stent 
peritonitis- CASP). This solves one of the problems that can occur 
with CLP, which is the formation of an intra-abdominal swelling 
instead of septic shock from peritonitis. CASP is a relatively new 
and rare case of diffuse peritonitis polymicrobial that reproduces 
the symptoms of acute peritonitis,[11] in addition to altering 
the blood flow with necro-secondary effects on the intestinal 
wall. The main disadvantage of CASP compared to CLP is its 
complexity. The model developed in this study starts from the 
reference in the literature to generate monomicrobial peritonitis 
with E. coli. Sanchez et al.[11] described lethal doses in healthy 
rats, with cirrhosis with and without ascites, applying E. coli to 
different concentrations and dilutions in healthy rats between 
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192 and 225 g. They noted short-term mortality in <48 h with 
a .9 ml inoculum of E. coli with 10 and 10 CFU diluted in 18 ml 
of sterile water (81% and 98% E. coli, respectively) significantly 
increased mortality. However, they note that same doses in 
healthy rats with weights of 470–510 g do not present mortality. 
This leads them to conclude that mortality may be directly related 
with the volume injected into the peritoneal cavity.[12,13] Authors 
describe how rats with crisis without ascites show that short-term 
mortality depends on day of administered E. coli concentration. 
When concentrations are low in E. coli (0.9 CFU/ml), only one 
rat dies (1/16). However, when inoculating 0.9 CFU/ml of E. coli, 
it was observed that the mortality increases, but significantly 
less compared to that produced with 0.9 CFU/ml.[14] This model 
agrees with what was found by other authors[13] and is similar to 
that described in the model that we present. In our model, 0.9 ml 
of E. coli with 9, 7, and 6 CFU, based on the concentration, high 
tractions independent of volume were enough to produce sepsis 
without any mortality. In second instance, a concentration of 9 
CFU is inoculated, adding a dilution volume of 12 and 16 ml of 
sterile water to corroborate that both concentration and volume 
are determinants in the development of sepsis. However, with 
these premises, we find a mortality of 37% in the cases received 
8 ml, while those who receive 16 ml die 100% in <5 h. This 
coincides with what is described in literature, although in our 
case, the administered volume is slightly lower than that used 
in other works.[12] Finally, when carrying out the therapeutic trial, 
it is confirmed that 100% of control rats perish within the first 
flush 5 h by inoculation of E. coli with 9 CFU diluted in 16 ml. This 
monobacterial experimental model presents certain advantages 
and disadvantages. On the one hand, knowing the germ, the 
strain and the amount of the inoculum that we administer can 
be very useful in the study of pathophysiological changes of 
sepsis, since we are able to control the conditions under which it 
is produced. Some authors[14] affirm that this model in rodents is 
capable of reproducing various characteristic changes of human 
sepsis, but its clinical relevance is limited by the fact that high 
concentrations of the bacteria in a model with a host unable 
to locate the infection, unlike what has been happening in 
humans.[15] In addition, most models infect healthy rats without 
comorbidities unlike humans where the most vulnerable 
populations are the extremes of life with comorbidities and where 
the treatment of sepsis is multidisciplinary including nutrition 
strategies, ventilation separatory, and hemodynamic support. 
So far, they have described many models of sepsis in animal 
experimentation, but none can fully reproduce sepsis in human 
hands since it is a heterogeneous, dependent on process of the 
genetic susceptibility of each individual and is accompanied by 
the significant comorbidities and drug consumption.[14] Research 
lines are currently focused on the use of “humanized” mice. These 
are mice that are transplanted with human hematopoietic stem 
cells they carry out the inflammatory response.[16,17] The main 
disadvantage is to obtain these mice the procedure it is slow and 
expensive. Another way to improve models would be to get older 
mice with/without comorbidity associated data.
The model described here establishes a lethal dose of 
E. coli10 10 CFU diluted in 16 ml sterile water. After an injection, 
intraperitoneal generates an effective, controlled, and easy 
infection reproducible set that could serve as the basis portion of 
future lines of research.
co n c lu s I o n
 Most models infect healthy rats without comorbidities unlike humans 
where the most vulnerable populations are the extremes of life with 
comorbidities and where the treatment of sepsis is multidisciplinary 
including nutrition strategies, ventilation separatory, and 
hemodynamic support. So far, they have described many models of 
sepsis in animal experimentation, but none can fully reproduce sepsis 
in human hands since it is a heterogeneous, dependent on process of 
the genetic susceptibility of each individual and is accompanied by 
the significant comorbidities and drug consumption.
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